Molecular Formula | C22H22F3N3O3 |
Molar Mass | 433.42 |
Density | 1.38 |
Melting Point | >225°C (dec.) |
Boling Point | 641.3±55.0 °C(Predicted) |
Solubility | DMSO 28 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
Appearance | Solid |
Color | Pale Yellow |
pKa | -2.70±0.30(Predicted) |
Storage Condition | -20°C Freezer |
In vitro study | GSK-2636771 has selective inhibitory activity against PTEN-deficient cell lines (human prostate cancer PC-3 and breast cancer HCC70) with EC50 of 36 nM and 72 nM, respectively. |
In vivo study | These xenograft models were treated GSK-2636771 to reduce the level of the phosphorylated protein kinase Akt(Ser473). Treatment of mice with GSK-2636771(100 mg/kg) did not increase glucose/insulin levels. |